Sign Out
No formal interaction studies have been performed.
For the adjunctive use of verteporfin photodynamic therapy (PDT) and ranibizumab in wet AMD, and PM, see Pharmacology: Pharmacodynamics: CLINICAL STUDIES under Actions.
For the adjunctive use of laser photocoagulation and ranibizumab in DME and BRVO, see Pharmacology: Pharmacodynamics: CLINICAL STUDIES under Actions and DOSAGE & ADMINISTRATION.
In clinical studies for the treatment of visual impairment due to DME, the outcome with regard to visual acuity or central retinal subfield thickness (CSFT) in patients treated with ranibizumab was not affected by concomitant treatment with thiazolidinediones.
Pediatric population: No interaction studies have been performed.
